Profile
M.
David MacFarlane worked as an Independent Director at Titan Pharmaceuticals, Inc. from 2011 to 2023.
Prior to that, he was the Vice President of Regulatory Affairs at Genentech, Inc. from 1989 to 1999.
He also held the same position at Glaxo, Inc.
Former positions of M. MacFarlane
| Companies | Position | End |
|---|---|---|
| TITAN PHARMACEUTICALS, INC. | Director/Board Member | 2023-06-28 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | General Counsel | 1999-07-31 |
| Glaxo, Inc. | General Counsel | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Glaxo, Inc. |
- Stock Market
- Insiders
- M. MacFarlane
